HONG KONG, Nov. 18, 2011 /PRNewswire-Asia-FirstCall/ --
China Cord Blood Corporation (NYSE: CO) ("the Company") today
announced its plan to release financial results for the second
quarter and first half of fiscal year 2012 on Monday, November 28, 2011, after market close in
the US.
The Company will host a conference call at 8:00 a.m. ET on Tuesday,
November 29, 2011 to discuss its financial performance and
give a brief overview of the Company's recent developments,
followed by a question and answer session. Interested parties
may access the audio webcast through the Company's IR website at
http://ir.chinacordbloodcorp.com. A replay of the webcast will be
accessible two hours after the presentation and available for three
weeks at the same URL link above. Listeners may also access
the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers
or +852-2475-0994 for Hong Kong
callers, access code: 20456843.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company to the operator.
Supplemental financial information referenced in the conference
call and the second quarter fiscal 2012 earnings press release will
be available at http://www.chinacordbloodcorp.com, in the section
titled Investor Center/Press Release, after 4:00 p.m. ET on Monday,
November 28, 2011.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and is
the only cord blood banking operator with multiple licenses.
Under current PRC government regulations, only one licensed
cord blood banking operator is permitted to operate in each
licensed region and only seven licenses have been authorized as of
today. China Cord Blood Corporation provides cord blood collection,
laboratory testing, hematopoietic stem cell processing and stem
cell storage services. For more information, please visit the
Company's website at http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Ms. Joeling Law
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
In New York: Ashley De Simone: 1-646-277-1227
In Beijing: Wen Lei Zheng: +86-10-6583-7510
SOURCE China Cord Blood Corporation